Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Receivables (2021 - 2024)

Opus Genetics (IRD) has disclosed Receivables for 5 consecutive years, with $10.1 million as the latest value for Q3 2023.

  • On a quarterly basis, Receivables changed N/A to $10.1 million in Q3 2023 year-over-year; TTM through Sep 2023 was $10.1 million, a N/A change, with the full-year FY2022 number at $1.3 million, changed N/A from a year prior.
  • Receivables was $10.1 million for Q3 2023 at Opus Genetics, up from $135000.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $10.1 million in Q3 2023 to a low of $50000.0 in Q2 2021.
  • A 3-year average of $2.9 million and a median of $1.3 million in 2022 define the central range for Receivables.